Opinion: What happens to health care if Alberta separates? - Yahoo News Canada

From chicken soup and honey to vitamin C and wet hair, Dr. Guy Choshen examines common cold remedies, separating those that may ease symptoms from those that lack scientific evidence and explaining when medical attention is neededynet|As winter approaches, the familiar box of tissues returns to the table, along with a flood of well-meaning advice on how to ward off a cold. Every household has at least one traditional remedy passed down through generations: hot chicken soup when a runny nose starts, a glass of orange juice to "boost the immune system" and the familiar warning at the door: "You're not going outside with wet hair! "But there can be a considerable gap between grandmother's wisdom and what modern medicine tells us. Dr. Guy Choshen, head of Internal Medicine Department B at Meir Medical Center, part of Israel's Clalit Health Services, examines the most common home remedies and myths surrounding colds, distinguishing between what works, what does no harm and what simply isn't true. GalleryWhich remedies actually work and which just have good publicity?

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.